SCHEMBL6974840

SCHEMBL6974840

CCC1CC(=O)c2ccccc2N1C(=O)c1ccc(OC)c(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.56
BCHE P06276 2/20 0.46
ACHE P22303 2/20 0.46
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
ALDH1A1 P00352 3/20 0.44
POLB P06746 1/20 0.44
CYP2C19 P33261 1/20 0.44
SIRT3 Q9NTG7 1/20 0.44
MAPK1 P28482 1/20 0.43
KDM4E B2RXH2 3/20 0.43
LMNA P02545 1/20 0.43
F12 P00748 1/20 0.42
TSHR P16473 1/20 0.42
P2RY1 P47900 1/20 0.42
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6420547 0.85 MCL1 (0.73) MCL1BCHEACHEPDE4APDE4B
SCHEMBL6979856 0.79 MCL1 (0.55) MCL1BCHEACHEPDE4APDE4B
SCHEMBL6979854 0.79 MCL1 (0.55) MCL1BCHEACHEPDE4APDE4B
SCHEMBL6979858 0.79 MCL1 (0.55) MCL1BCHEACHEPDE4APDE4B
SCHEMBL6418688 0.74 PDE4A (0.65) MCL1BCHEACHEPDE4APDE4B
SCHEMBL6975946 0.73 P2RY1 (0.50) MCL1PDE4APDE4BPDE4CPDE4D
SCHEMBL6420734 0.70 MCL1 (0.51) MCL1BCHEACHEPDE4APDE4B
SCHEMBL6425432 0.69 MEN1 (0.66) MCL1BCHEACHEPDE4APDE4B
SCHEMBL6420033 0.68 MCL1 (0.57) MCL1BCHEACHEPDE4APDE4B
SCHEMBL6420261 0.68 MCL1 (0.49) MCL1BCHEACHEPDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216398-A1 Soluble beta amyloid precursor protein secretion promoters TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2003-11-20 US disclosed
EP-1283055-A1 SOLUBLE BETA AMYLOID PRECURSOR PROTEIN SECRETION PROMOTERS Takeda Chemical Industries, Ltd. (JP) 2003-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216398-A1 Soluble beta amyloid precursor protein secretion promoters APP, BDNF, BACE1 MCL1 1131/4885BCHE 235/4885ACHE 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.